Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 63,212 | 69,142 | 31,185 | 34,303 | 37,395 |
| Receivables | 148 | 124 | 606 | 112 | 244 |
| TOTAL | $63,823 | $69,421 | $31,947 | $34,621 | $37,840 |
| Non-Current Assets | |||||
| PPE Net | 748 | 721 | 748 | 639 | 548 |
| Intangibles | 40,647 | 40,850 | 41,053 | 38,784 | 38,930 |
| Other Non-Current Assets | 66 | 66 | 66 | 108 | 102 |
| TOTAL | $41,461 | $41,637 | $41,867 | $39,531 | $39,580 |
| Total Assets | $105,284 | $111,058 | $73,814 | $74,152 | $77,420 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,463 | 7,694 | 5,913 | 6,105 | 1,042 |
| TOTAL | $6,065 | $8,296 | $6,515 | $8,707 | $7,644 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | 602 | 602 | 602 | 602 |
| TOTAL | $3,513 | $3,664 | $3,814 | $3,965 | $4,115 |
| Total Liabilities | $9,578 | $11,960 | $10,329 | $12,672 | $11,759 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,610 | 1,610 | 1,598 | 1,342 | 1,312 |
| Common Shares | 403 | 403 | 338 | 328 | 328 |
| Retained earnings | -337,720 | -332,473 | -325,471 | -322,847 | -316,144 |
| TOTAL | $95,706 | $99,098 | $63,485 | $61,480 | $65,661 |
| Total Liabilities And Equity | $105,284 | $111,058 | $73,814 | $74,152 | $77,420 |